litlas
Log inCreate account

Mingzhao Xing

Active 1997–2025

82
Papers
19,872
Citations
68
h-index
79
i10-index

Citations

Citations per year for Mingzhao Xing1998: 5 citations1999: 1 citations2000: 12 citations2001: 7 citations2002: 2 citations2003: 11 citations2004: 41 citations2005: 89 citations2006: 138 citations2007: 139 citations2008: 140 citations2009: 157 citations2010: 122 citations2011: 180 citations2012: 141 citations2013: 242 citations2014: 225 citations2015: 193 citations2016: 244 citations2017: 230 citations2018: 115 citations2019: 832 citations2020: 926 citations2021: 713 citations2022: 394 citations2023: 291 citations2024: 381 citations2025: 186 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,176 citing papers, 25.9% of this breakdownChina: 756 citing papers, 16.6% of this breakdownItaly: 358 citing papers, 7.9% of this breakdownSouth Korea: 170 citing papers, 3.7% of this breakdownUnited Kingdom: 148 citing papers, 3.2% of this breakdownGermany: 147 citing papers, 3.2% of this breakdownJapan: 141 citing papers, 3.1% of this breakdownCanada: 114 citing papers, 2.5% of this breakdownFrance: 113 citing papers, 2.5% of this breakdownSpain: 108 citing papers, 2.4% of this breakdownAustralia: 99 citing papers, 2.2% of this breakdownIndia: 94 citing papers, 2.1% of this breakdown
0%25.9%Other 24.7%

Institutions

Fields

  • Medicine69.7%
  • Biochemistry, Genetics and Molecular Biology26.5%
  • Computer Science0.8%
  • Immunology and Microbiology0.7%
  • Environmental Science0.6%
  • Nursing0.3%
  • Other1.4%

Topics

  • Thyroid Cancer Diagnosis and Treatment16.9%
  • Thyroid Disorders and Treatments5.1%
  • Thyroid and Parathyroid Surgery4.2%
  • Cancer-related Molecular Pathways3.2%
  • BRCA gene mutations in cancer2.4%
  • COVID-19 Clinical Research Studies2.4%
  • Other65.8%

Coauthors

All papers

Open in search
  1. Molecular pathogenesis and mechanisms of thyroid cancer

    Authors: Mingzhao Xing - Nature reviews. Cancer 2013 cited by 1,434

  2. BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

    Authors: Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A. Zeiger, Sara I. Pai, Justin A. Bishop - Journal of Clinical Oncology 2014 cited by 715

  3. TERT promoter mutations in thyroid cancer

    Authors: Rengyun Liu, Mingzhao Xing - Endocrine Related Cancer 2016 cited by 435

  4. Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

    Authors: Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson, David Viola, Rossella Elisei, Běla Bendlová, Linwah Yip, Caterina Mian, Federica Vianello, R. Michael Tuttle, Eyal Robenshtok, James A. Fagin, Efisio Puxeddu, Laura Fugazzola, Agnieszka Czarniecka, Barbara Jarząb, Christine J. O’Neill, Mark Sywak, Alfred K. Lam, Garcilaso Riesco‐Eizaguirre, Pilar Santisteban, Hirotaka Nakayama, Ralph P. Tufano, Sara I. Pai, Martha A. Zeiger, William H. Westra, Douglas P. Clark, Roderick Clifton‐Bligh, David Sidransky, Paul W. Ladenson, Vlasta Sýkorová - JAMA 2013 cited by 926

  5. Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

    Authors: Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Běla Bendlová, Linwah Yip, Caterina Mian, Federica Vianello, R. Michael Tuttle, Eyal Robenshtok, James A. Fagin, Efisio Puxeddu, Laura Fugazzola, Agnieszka Czarniecka, Barbara Jarząb, Christine J. O’Neill, Mark Sywak, Alfred K. Lam, Garcilaso Riesco‐Eizaguirre, Pilar Santisteban, Hirotaka Nakayama, Roderick Clifton‐Bligh, Giovanni Tallini, Elizabeth H. Holt, Vlasta Sýkorová - Journal of Clinical Oncology 2014 cited by 521

  6. BRAF mutation in thyroid cancer

    Authors: Mingzhao Xing - Endocrine Related Cancer 2005 cited by 1,313

  7. BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

    Authors: Mingzhao Xing - Endocrine Reviews 2007 cited by 989

  8. Highly prevalent TERT promoter mutations in aggressive thyroid cancers

    Authors: Xiaoli Liu, Justin A. Bishop, Yuan Shan, Sara I. Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K. El‐Naggar, Mingzhao Xing - Endocrine Related Cancer 2013 cited by 607

  9. Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer

    Authors: Rengyun Liu, Justin A. Bishop, Guangwu Zhu, Tao Zhang, Paul W. Ladenson, Mingzhao Xing - JAMA Oncology 2016 cited by 289

  10. Progress in molecular-based management of differentiated thyroid cancer

    Authors: Mingzhao Xing, Bryan R. Haugen, Martin Schlumberger - The Lancet 2013 cited by 572

  11. The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer

    Authors: Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li, Mingzhao Xing - Journal of Nuclear Medicine 2019 cited by 132

  12. Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

    Authors: Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing - Nature Communications 2018 cited by 182

  13. TERTPromoter Mutations and Their Association withBRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer

    Authors: Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang, Hui Sun, Zhongyan Shan, Weiping Teng, Mingzhao Xing - The Journal of Clinical Endocrinology & Metabolism 2014 cited by 316

  14. BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer

    Authors: Mingzhao Xing, William H. Westra, Ralph P. Tufano, Yoram Cohen, Eli Rosenbaum, Kerry J. Rhoden, Kathryn A. Carson, Vasily Vasko, О. С. Ларін, Giovanni Tallini, Sara M. Tolaney, Elizabeth H. Holt, Pei Hui, Christopher B. Umbricht, Shehzad Basaria, Marge Ewertz, Anthony P. Tufaro, Joseph A. Califano, Matthew D. Ringel, Martha A. Zeiger, David Sidransky, Paul W. Ladenson - The Journal of Clinical Endocrinology & Metabolism 2005 cited by 994

  15. Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer

    Authors: Mingzhao Xing - BMC Medicine 2016 cited by 107

  16. BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment

    Authors: Ralph P. Tufano, Gilberto Teixeira, Justin A. Bishop, Kathryn A. Carson, Mingzhao Xing - Medicine 2012 cited by 306

  17. Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer

    Authors: Mingzhao Xing - Thyroid 2010 cited by 303

  18. Recent incidences and differential trends of thyroid cancer in the USA

    Authors: Yushan Mao, Mingzhao Xing - Endocrine Related Cancer 2016 cited by 208

  19. A Novel Role for Thyroid-Stimulating Hormone: Up-Regulation of Hepatic 3-Hydroxy-3-Methyl-Glutaryl-Coenzyme A Reductase Expression Through the Cyclic Adenosine Monophosphate/Protein Kinase A/Cyclic Adenosine Monophosphate–Responsive Element Binding Protein Pathway

    Authors: Limin Tian, Yongfeng Song, Mingzhao Xing, Wei Zhang, Guang Ning, Xiaoying Li, Chunxiao Yu, Chengkong Qin, Jun Liu, Xingsong Tian, Xianglan Sun, Rui Fu, Lin Zhang, Xiujuan Zhang, Yan Lu, Jianwen Zou, Laicheng Wang, Qingbo Guan, Ling Gao, Jiajun Zhao - Hepatology 2010 cited by 163

  20. BRAF Mutation in Papillary Thyroid Carcinoma

    Authors: Yoram Cohen, Mingzhao Xing, Elizabeth Mambo, Zhihong Guo, G. Wu, Barry Trink, Uziel Beller, William H. Westra, Paul W. Ladenson, D. Sidransky - JNCI Journal of the National Cancer Institute 2003 cited by 924

  21. Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility

    Authors: Jiao Zhao, Yan Yang, Han-Ping Huang, Li Dong, Dongfeng Gu, Xiangfeng Lu, Zheng Zhang, Lei Liu, Ting Liu, Yukun Liu, Yunjiao He, Bin Sun, Meilan Wei, Guangyu Yang, Xinghuan Wang, Li Zhang, Xiaoyang Zhou, Mingzhao Xing, Peng George Wang - Clinical Infectious Diseases 2020 cited by 572

  22. Genetic Alterations and Their Relationship in the Phosphatidylinositol 3-Kinase/Akt Pathway in Thyroid Cancer

    Authors: Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K. El‐Naggar, Giovanni Tallini, Vasily Vasko, Mingzhao Xing - Clinical Cancer Research 2007 cited by 417

  23. Association of High Iodine Intake with the T1799A BRAF Mutation in Papillary Thyroid Cancer

    Authors: Haixia Guan, Meiju Ji, Rong Bao, H.Y. Yu, Yangang Wang, Peng Hou, Yong Zhang, Zhongyan Shan, Weiping Teng, Mingzhao Xing - The Journal of Clinical Endocrinology & Metabolism 2009 cited by 223

  24. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

    Authors: Shuiying Hu, Dingxie Liu, Ralph P. Tufano, Kathryn A. Carson, Eli Rosenbaum, Yoram Cohen, Elizabeth H. Holt, Katja Kiseljak‐Vassiliades, Kerry J. Rhoden, Sara M. Tolaney, Stephen Condouris, Giovanni Tallini, William H. Westra, Christopher B. Umbricht, Martha A. Zeiger, Joseph A. Califano, Vasily Vasko, Mingzhao Xing - International Journal of Cancer 2006 cited by 197